These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9153156)

  • 1. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease.
    Borson S; Raskind MA
    Neurology; 1997 May; 48(5 Suppl 6):S17-24. PubMed ID: 9153156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of behavioral problems in Alzheimer's disease.
    Gauthier S; Cummings J; Ballard C; Brodaty H; Grossberg G; Robert P; Lyketsos C
    Int Psychogeriatr; 2010 May; 22(3):346-72. PubMed ID: 20096151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas.
    Omerovic M; Hampel H; Teipel SJ; Buerger K
    World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
    Hake AM
    Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.
    Lee D; Clark ED; Antonsdottir IM; Porsteinsson AP
    Expert Opin Pharmacother; 2023 Apr; 24(6):691-703. PubMed ID: 36958727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the advancements in the treatment of agitation in Alzheimer's disease.
    Porsteinsson AP; Antonsdottir IM
    Expert Opin Pharmacother; 2017 Apr; 18(6):611-620. PubMed ID: 28300462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progresses in treating agitation: a major clinical challenge in Alzheimer's disease.
    Panza F; Solfrizzi V; Seripa D; Imbimbo BP; Santamato A; Lozupone M; Prete C; Greco A; Pilotto A; Logroscino G
    Expert Opin Pharmacother; 2015; 16(17):2581-8. PubMed ID: 26389682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacologic treatment of Alzheimer's disease: a guide for the general psychiatrist.
    Flint AJ; van Reekum R
    Can J Psychiatry; 1998 Sep; 43(7):689-97. PubMed ID: 9773218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: pharmacological treatment and management.
    Rivas-Vazquez RA; Carrazana EJ; Rey GJ; Blais MA; Racher DA
    Clin Neuropsychol; 2000 Feb; 14(1):93-109. PubMed ID: 10855063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to manage depression and psychosis in Alzheimer's disease.
    Tueth MJ
    Geriatrics; 1995 Jan; 50(1):43-6, 49. PubMed ID: 7821828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease.
    Cummings JL; Nadel A; Masterman D; Cyrus PA
    J Geriatr Psychiatry Neurol; 2001; 14(2):101-8. PubMed ID: 11419566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive therapy in patients with Alzheimer's disease. A practical approach.
    Corey-Bloom J; Galasko D
    Drugs Aging; 1995 Aug; 7(2):79-87. PubMed ID: 7579786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
    Raskind MA
    Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treated Behavioral Symptoms and Mortality in Medicare Beneficiaries in Nursing Homes with Alzheimer's Disease and Related Dementias.
    Huang TY; Wei YJ; Moyo P; Harris I; Lucas JA; Simoni-Wastila L
    J Am Geriatr Soc; 2015 Sep; 63(9):1757-65. PubMed ID: 26310959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.